HLTH News and Press, Cue Health Inc. From 05/09/23

Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced that it has made a De Novo submission to the U.S. Food and Drug Administration (FDA) for full clearance of the Cue RSV Molecular Test for at-home and point-of-care use. There are currently no respira...

Cue now offers over-the-counter and prescription medications for sexual health, birth control, hair loss, and more Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced an expansion of its Cue Integrated Care Platform to include a new phar...

Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its first quarter 2023 financial results on Wednesday, May 10, 2023. In conjunction with the release, Cue will host a conference call and webcast that day at 1:30 p.m. Pacif...

Vancouver, British Columbia--(Newsfile Corp. - March 24, 2023) - Global Care Capital Inc. (CSE: HLTH ) ( FSE : L6V2 ) (the " Company " or " Global Care ") announces further to its News Release dated March 22, 2023 that the Canadian Securities Exchange has accepted the Company's name to chan...

Toronto, Ontario--(Newsfile Corp. - Le 24 mars/March 2023) - Global Care Capital Inc. (HLTH) has announced a name and symbol change to Polaris Northstar Capital Corp. (POLE) and a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for ...

Vancouver, British Columbia--(Newsfile Corp. - March 22, 2023) - Global Care Capital Inc. (CSE: HLTH )   (FSE : L6V2 ) (the " Company " or " Global Care ") a global investment company which engages in early-stage investment opportunities in private and public companies, announces that the...

2023-03-20 12:31:25 ET San Diego, CA-based diagnostics company Cue Health ( NASDAQ: HLTH ) announced Monday that the FDA issued Emergency Use Authorization for a molecular test to detect the mpox virus, formerly identified as monkeypox. The nucleic acid amplification test ...

Authorized to be used in professional point-of-care settings, the nucleic acid amplification test can detect mpox virus and deliver results in 25 minutes Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced it has received Emergency...

2023-03-15 22:32:06 ET Cue Health, Inc. (HLTH) Q4 2022 Earnings Conference Call March 15, 2023, 04:30 PM ET Company Participants Lorna Williams - IR Ayub Khattak - Co-Founder, President, CEO & Chairman Aasim Javed - CFO Conference Call Participants ...

2023-03-15 16:05:50 ET Cue Health press release ( NASDAQ: HLTH ): Q4 Non-GAAP EPS of -$0.50 beats by $0.04 . Revenue of $146.78M (-23.8% Y/Y). Shares -5.47% . For further details see: Cue Health Non-GAAP EPS of -$0.50 beats by $0.04, revenue of $146.78M